Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

88.23M

Market cap88.23M

Price-Earnings ratio

-2.66

Price-Earnings ratio-2.66

Dividend yield

—

Dividend yield—

Average volume

3.15M

Average volume3.15M

High today

$0.61

High today$0.61

Low today

$0.582

Low today$0.582

Open price

$0.59

Open price$0.59

Volume

1.57M

Volume1.57M

52 Week high

$1.42

52 Week high$1.42

52 Week low

$0.45

52 Week low$0.45

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.